Market Tracker

07/31 6:05pm ET

PDL BioPharma Inc (NASDAQ:PDLI)

During the Trading Day
9.38 -0.02 / -0.21%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
9.38 0.00 / 0.00%
 
Volume: 158.4K

Today’s Trading

Previous close9.40
Today’s open9.35
Day’s range9.24 - 9.45
Volume2,857,999
Average volume (3 months)2,096,148
Market cap$1.5B
Dividend yield6.40%
Data as of 4:00pm ET, 07/31/2014

Growth & Valuation

Earnings growth (last year)+14.48%
Earnings growth (this year)+12.25%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+18.26%
P/E ratio5.3
Price/Sales2.66
Price/Book11.59

Competitors

 Today’s
change
Today’s
% change
MDCOMedicines Co-0.72-2.99%
RAREUltragenyx Pharmaceu...-0.06-0.14%
IPXLImpax Laboratories I...+0.02+0.09%
CLVSClovis Oncology Inc-2.03-5.28%
Data as of 4:00pm ET, 07/31/2014

Financials

Next reporting dateAugust 12, 2014
EPS forecast (this quarter)$0.46
Annual revenue (last year)$442.9M
Annual profit (last year)$264.5M
Net profit margin59.72%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts